Volastra Therapeutics

formerly Volastra

Volastra - Short Circuiting Cancer's Chaos

New York, United States · Founded 2019 · $134.1M raised

Headquarters
New York, New York
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$134.1M
Last Round
$30.1M Series BSep 2025
Rounds
3

About

Volastra Therapeutics is a clinical-stage oncology biotech company based in New York City, pioneering novel approaches to treating cancer by exploiting chromosomal instability (CIN). Founded by Lewis Cantley, Olivier Elemento, and Samuel Bakhoum, Volastra is advancing a synthetic lethal and immune-activating pipeline including two KIF18A inhibitors currently in Phase 1 clinical trials.

Summary

Volastra Therapeutics is a Biotech company based in New York, United States, founded in 2019. It has raised $134.1M in total across 3 rounds, most recently a $30.1M Series B round in Sep 2025. Investors include Andreessen Horowitz, B Capital Group and Eli Lilly.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2025
$30.1M

Sign up to see all 3 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Volastra Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/volastra-therapeutics"><img src="https://indexed.vc/api/badge/company/volastra-therapeutics" alt="Volastra Therapeutics on Indexed.vc" width="260" height="76" /></a>